This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of treprostinil oral inhalation: A Synthesis of Findings from 13 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of treprostinil oral inhalation: A Synthesis of Findings from 13 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major findings

Topiramate (TPM), a commonly prescribed anti-seizure medication, has been shown to have cognitive side effects in several studies. 12 investigated TPM's impact on cognition in healthy volunteers using a double-blind, randomized, placebo-controlled, crossover study. The study found that TPM impaired cognitive test performance, particularly in working memory tasks. 4 compared the cognitive effects of TPM and valproate (VPA) in adults with partial seizures and found that TPM had slightly worse overall cognitive effects than VPA, particularly in tests of symbol digit modalities and word association. 5 further confirmed the negative impact of TPM on cognitive function in a study of healthy volunteers, with TPM significantly impairing cognitive performance compared to placebo and gabapentin. 2 also observed potential acute and steady-state cognitive effects for TPM in healthy young adults, particularly in measures of attention and word fluency.

Benefits and Risks

Benefit Summary

Topiramate is an effective anti-seizure medication. 11 found that topiramate is associated with weight loss in clinical trials, suggesting a potential benefit for the treatment of obesity. 10 explored topiramate's potential for smoking cessation and found that it enhanced both nicotine withdrawal and reward, suggesting potential utility in managing cravings.

Risk Summary

Topiramate is associated with cognitive side effects, including impaired working memory, attention, and word fluency. These effects can potentially impact daily and occupational function. The risk of cognitive impairment may be greater in individuals taking topiramate for extended periods or at higher doses. 4 , 5 , 2

Comparison of Studies

Commonalities

All studies reviewed demonstrated that topiramate can have a negative impact on cognitive function. This effect was observed across different populations, including healthy volunteers, patients with epilepsy, and individuals with substance use disorders.

Differences

Studies differed in their specific cognitive measures, dosages, and patient populations. Some studies focused on specific cognitive domains, such as working memory or attention, while others evaluated broader cognitive function. 4 compared topiramate to another anti-seizure medication, valproate, and found that topiramate's negative cognitive effects were slightly more pronounced. 10 explored topiramate's potential for smoking cessation, while other studies focused primarily on its cognitive effects.

Consistency and Contradictions

The studies generally demonstrate a consistent pattern of negative cognitive effects associated with topiramate use. However, the magnitude of these effects and the specific cognitive domains affected can vary depending on factors such as dosage, treatment duration, and individual susceptibility.

Real-World Applications

Individuals taking topiramate should be aware of the potential cognitive side effects. It is important to discuss these potential risks with a healthcare professional. Monitoring cognitive function and adjusting the dosage or treatment regimen may be necessary to mitigate any significant cognitive impairment.

Limitations of Current Research

The studies reviewed have some limitations, including the relatively small sample sizes, specific patient populations, and focus on acute or short-term effects. More research is needed to better understand the long-term effects of topiramate on cognitive function and to determine the potential impact of different dosage regimens.

Future Research Directions

Further research is needed to understand the mechanisms underlying topiramate's cognitive effects. It is important to investigate how topiramate interacts with the brain to produce these cognitive changes. Additionally, research is needed to develop strategies for mitigating these effects or to identify individuals who may be more susceptible to cognitive impairment.

Conclusion

Topiramate can have a significant impact on cognitive function, particularly in working memory, attention, and language processing. Individuals taking topiramate should be aware of these potential side effects and should discuss their concerns with a healthcare professional. Future research is needed to better understand the mechanisms of topiramate's cognitive effects and to develop strategies for mitigating these effects.


Literature analysis of 13 papers
Positive Content
9
Neutral Content
2
Negative Content
2
Article Type
11
2
0
1
13

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.